Feb 17 (Reuters) - Biopharmaceutical firm Bionomics Ltd (BNO) said on Wednesday it signed an agreement with EmpathBio Inc, a unit of Germany's atai Life Sciences, to look at combining their drug treatments aimed at post-traumatic stress disorder (PTSD).
The memorandum of understanding between Bionomics and EmpathBio will focus on using different combinations of their drug treatments to form a better treatment regimen for PTSD.
News: BNO Bionomics and EmpathBio to assess treatment combinations for PTSD
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)